Both management tools to work with to ensure the required biofilm profiling of microbes, parasites and bions in agriculture and public health.
Basic research with bions, biomimetic properties and respecting the basic physiology of blood circulation which pulsates naturally in mammals and therefore in humans led to a novel and differentiated Heart Device.
Protlab GPL Limited has been awarded:
Presentation on the Human Genome Meeting 2017 from 5 to 7 February 2017, in Barcelona as well on the 19th International Conference on Obstetrics and Gynaecology from 16 to 17 February 2017, in London
Furthermore on 'The Molecular Diagnostics Europe Conference', summit on 11 to 12 April 2017 in Lisbon, Portugal at the Sheraton Hotel.
Mr John Erb (Chairman and CEO, CHF Solutions Inc., a NASDAQ listed company) has accepted to come on board of Protlab GPL, Ltd as a new director.
He has more than 35years experience in medical device industry.
Credo ut intelligam - 'I believe so that I may understand'
Intellego ut credam - 'I think so that I may believe'
Anselm of Canterbury